PTE, a novel module to target Polycomb Repressive Complex 1 to the human cyclin D2 (CCND2) oncogene

J Biol Chem. 2018 Sep 14;293(37):14342-14358. doi: 10.1074/jbc.RA118.005010. Epub 2018 Aug 1.

Abstract

Polycomb group proteins are essential epigenetic repressors. They form multiple protein complexes of which two kinds, PRC1 and PRC2, are indispensable for repression. Although much is known about their biochemical properties, how mammalian PRC1 and PRC2 are targeted to specific genes is poorly understood. Here, we establish the cyclin D2 (CCND2) oncogene as a simple model to address this question. We provide the evidence that the targeting of PRC1 to CCND2 involves a dedicated PRC1-targeting element (PTE). The PTE appears to act in concert with an adjacent cytosine-phosphate-guanine (CpG) island to arrange for the robust binding of PRC1 and PRC2 to repressed CCND2 Our findings pave the way to identify sequence-specific DNA-binding proteins implicated in the targeting of mammalian PRC1 complexes and provide novel link between polycomb repression and cancer.

Keywords: PRC1; chromatin; cyclin D2; epigenetics; gene silencing; oncogene; polycomb; polycomb targeting.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding Sites
  • Cyclin D2 / genetics*
  • Cyclin D2 / metabolism*
  • Gene Silencing
  • Humans
  • Mice
  • Oncogenes*
  • Polycomb-Group Proteins / metabolism*
  • Protein Binding
  • Transcription, Genetic

Substances

  • CCND2 protein, human
  • Cyclin D2
  • Polycomb-Group Proteins